796.60
-6.00
(-0.75%)
At close: January 30 at 5:24:48 PM GMT+2
Breakdown
12/31/2023
12/31/2022
8/31/2021
8/31/2020
Total Assets
220,551.00
161,642.00
127,999.00
44,633.00
Total Liabilities Net Minority Interest
57,658.00
10,486.00
11,482.00
11,754.00
Total Equity Gross Minority Interest
162,893.00
151,156.00
116,517.00
32,879.00
Total Capitalization
163,821.00
151,812.00
115,773.00
32,879.00
Common Stock Equity
163,821.00
151,812.00
115,773.00
32,879.00
Capital Lease Obligations
609.00
894.00
533.00
75.00
Net Tangible Assets
163,821.00
151,812.00
115,773.00
32,879.00
Working Capital
109,370.00
151,363.00
88,658.00
35,975.00
Invested Capital
214,834.00
151,812.00
115,773.00
32,879.00
Tangible Book Value
163,821.00
151,812.00
115,773.00
32,879.00
Total Debt
51,622.00
894.00
533.00
75.00
Net Debt
41,958.00
--
--
--
Share Issued
40,338.98
39,563.89
35,293.89
23,675.53
Ordinary Shares Number
40,338.98
39,563.89
35,293.89
23,675.53
8/31/2020 - 7/13/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
223.00
-5.55%
PPBT.TA Purple Biotech Ltd
5.90
-4.84%
ENLV.TA Enlivex Therapeutics Ltd.
396.00
-0.63%
BLRX.TA BioLineRx Ltd.
2.4000
-25.00%
XTLB XTL Biopharmaceuticals Ltd.
1.5899
-1.25%
PPBT Purple Biotech Ltd
3.2500
-3.85%
ENLV Enlivex Therapeutics Ltd.
1.1000
-0.90%
BCLI Brainstorm Cell Therapeutics Inc.
1.8200
-6.19%
IVVD Invivyd, Inc.
0.3577
-8.28%
CGEN Compugen Ltd.
2.3300
-0.85%